Wockhardt wins “BIRAC Innovator Award 2024”
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Secretary Vaidya Rajesh Kotecha has urged senior officials to strive for the successful attainment of targets during the campaign
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
Wanbury receives CEP approval from EDQM for launch of Dextromethorphan API
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
These accolades highlight our unwavering commitment to maintaining the highest safety standards
Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management
The clinical trial will be conducted at 19 sites with 10,335 participants across India
Subscribe To Our Newsletter & Stay Updated